Detalhe da pesquisa
1.
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
PLoS Med
; 17(9): e1003222, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956407
2.
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.
Pharmacol Res
; 136: 140-150, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30219580
3.
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
JAMA Neurol
; 79(10): 1005-1014, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036925
4.
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function.
Neurology
; 93(13): e1312-e1323, 2019 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31451516